Last updated: 23 June 2020 at 7:48am EST

Benjamin Shaw Net Worth




The estimated Net Worth of Benjamin Shaw is at least $22.1 million dollars as of 21 August 2019. Benjamin Shaw owns over 39,566 units of Covetrus stock worth over $22,102,428 and over the last 5 years Benjamin sold CVET stock worth over $0.

Benjamin Shaw CVET stock SEC Form 4 insiders trading

Benjamin has made over 1 trades of the Covetrus stock since 2019, according to the Form 4 filled with the SEC. Most recently Benjamin exercised 39,566 units of CVET stock worth $125,029 on 21 August 2019.

The largest trade Benjamin's ever made was exercising 39,566 units of Covetrus stock on 21 August 2019 worth over $125,029. On average, Benjamin trades about 39,566 units every 0 days since 2019. As of 21 August 2019 Benjamin still owns at least 1,052,998 units of Covetrus stock.

You can see the complete history of Benjamin Shaw stock trades at the bottom of the page.



What's Benjamin Shaw's mailing address?

Benjamin's mailing address filed with the SEC is 7, Custom House Street, India Street, Portland, Cumberland County, Maine, 04101, United States.

Insiders trading at Covetrus

Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin et Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.



What does Covetrus do?

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.



Complete history of Benjamin Shaw stock trades at Covetrus

Initié
Trans.
Transaction
Prix ​​total
Benjamin Shaw
Chief Executive Officer
Exercice d'option $125,029
21 Aug 2019


Covetrus executives and stock owners

Covetrus executives and other stock owners filed with the SEC include: